A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.
Reproductive history genetic health risk is deeper than lifestyle choices. A FinnGen preprint posted June 9, 2026 finds that ...
A study in zebrafish shows that neuronal microexons regulate brain activity by modulating cAMP signaling. Loss of these ...
Explore why scent compatibility between partners is becoming a key factor in modern relationships and how smell influences ...
The study reveals that prenatal fructose exposure directly alters neural stem cells (NSCs), the foundational master cells ...
Grant awarded through the Parkinson's Disease Therapeutics Pipeline Program tosupport advancement of Harness' new programme targeting GCase and LIMP2 for Parkinson's disease ...
The Garden Magazine on MSN
How Raindrops Safely Trigger a Plant's Internal Immune System
Rain does more than water a garden. Every time a drop lands on a leaf, something quietly remarkable happens inside the plant.
Pharmaceutical Technology on MSN
UniQure to seek approval of Huntington’s gene therapy after FDA U-turn
uniQure confirmed it will submit its BLA in Q3 2026, though there is still a required confirmatory study to conduct.
AstraZeneca announces positive results from MULBERRY phase III trial of efzimfotase alfa, an investigational enzyme replacement therapy: Cambridge, UK Tuesday, June 30, 2026, 11:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results